Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.656
-0.003 (-0.44%)
At close: Mar 13, 2025, 4:00 PM
0.681
+0.025 (3.81%)
After-hours: Mar 13, 2025, 4:02 PM EST
Rallybio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | - | -74.56 | -66.65 | -47.01 | -26.45 | |
| Depreciation & Amortization | - | 0.15 | 0.17 | 0.11 | 0.06 | |
| Loss (Gain) From Sale of Investments | - | -3.09 | -0.44 | - | - | |
| Loss (Gain) on Equity Investments | - | 2.04 | 1.08 | 1.51 | 1.52 | |
| Stock-Based Compensation | - | 10.92 | 9.5 | 3.65 | 0.7 | |
| Change in Accounts Payable | - | -0.1 | 0.49 | -0.98 | 0.72 | |
| Change in Other Net Operating Assets | - | 4.38 | -1.42 | -2.8 | 1.4 | |
| Operating Cash Flow | - | -60.27 | -57.28 | -45.53 | -22.04 | |
| Capital Expenditures | - | -0.01 | -0.05 | -0.33 | -0.14 | |
| Investment in Securities | - | 27.67 | -112.12 | -2 | -1.94 | |
| Investing Cash Flow | - | 27.66 | -112.17 | -2.33 | -2.07 | |
| Issuance of Common Stock | - | 0.28 | 51.77 | 86.2 | 145.21 | |
| Other Financing Activities | - | -0.14 | -0.69 | -3.23 | -0.32 | |
| Financing Cash Flow | - | 0.14 | 51.08 | 82.97 | 144.89 | |
| Net Cash Flow | - | -32.46 | -118.38 | 35.1 | 120.78 | |
| Free Cash Flow | - | -60.28 | -57.34 | -45.87 | -22.18 | |
| Free Cash Flow Per Share | - | -1.49 | -1.80 | -1.80 | -1.28 | |
| Levered Free Cash Flow | - | -34.15 | -33.77 | -28.91 | -12.75 | |
| Unlevered Free Cash Flow | - | -34.15 | -33.77 | -28.91 | -12.71 | |
| Change in Net Working Capital | - | -4.12 | 0.96 | 3.8 | -2.47 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.